Deschloroetizolam (also known as Etizolam-2) is a thienotriazolodiazepine that is the dechlorinated analog of the closely related etizolam.

[1][2][3] The compound has been sold as a designer drug.

[4][5][6][7] Deschloroetizolam is classified and controlled as a hazardous substance in Sweden as of on October 15, 2015.

[8] Deschloroetizolam was made schedule I at the state level in Alabama on July 15th, 2024.

[9] This sedative-related article is a stub.